Drugplain

LOreal Paris Bright Reveal Broad Spectrum SPF 50 Daily UV Sunscreen 30 mg/mL

Avobenzone, Homosalate, Octisalate and Octocrylene · LOTION · L'Oreal USA Products Inc

No Recall History
Plain English

LOreal Paris Bright Reveal Broad Spectrum SPF 50 Daily UV Sunscreen is a lotion containing avobenzone, homosalate, octisalate and octocrylene at 30 mg/mL, taken topical. Manufactured by L'Oreal USA Products Inc.

Key Facts

Brand Name
LOreal Paris Bright Reveal Broad Spectrum SPF 50 Daily UV Sunscreen
Generic Name
Avobenzone, Homosalate, Octisalate and Octocrylene
NDC Code (Product)
49967-996
Manufacturer
L'Oreal USA Products Inc
Strength
30 mg/mL
Dosage Form
LOTION
Route
TOPICAL
Marketing Status
Application #
M020
Marketing Start
05/13/2024

Recall History

No Recall History

Frequently Asked Questions

What is LOreal Paris Bright Reveal Broad Spectrum SPF 50 Daily UV Sunscreen used for?

LOreal Paris Bright Reveal Broad Spectrum SPF 50 Daily UV Sunscreen contains Avobenzone, Homosalate, Octisalate and Octocrylene. It is a lotion taken topical. Consult your doctor for specific uses.

Is LOreal Paris Bright Reveal Broad Spectrum SPF 50 Daily UV Sunscreen a controlled substance?

LOreal Paris Bright Reveal Broad Spectrum SPF 50 Daily UV Sunscreen is not classified as a controlled substance by the DEA.

What is the generic name for LOreal Paris Bright Reveal Broad Spectrum SPF 50 Daily UV Sunscreen?

The generic name for LOreal Paris Bright Reveal Broad Spectrum SPF 50 Daily UV Sunscreen is Avobenzone, Homosalate, Octisalate and Octocrylene. There are 11 other brand versions of Avobenzone, Homosalate, Octisalate and Octocrylene.

What is the NDC code for LOreal Paris Bright Reveal Broad Spectrum SPF 50 Daily UV Sunscreen 30 mg/mL?

The NDC (National Drug Code) for LOreal Paris Bright Reveal Broad Spectrum SPF 50 Daily UV Sunscreen 30 mg/mL is 49967-996, listed by L'Oreal USA Products Inc.

Product NDC

49967-996

Package NDC

49967-996-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)